Núcleo de Estudos de Doenças Auto-imunes

Sociedade Portuguesa de Medicina Interna
T: (+351) 217 520 570 / Email: info@nedai.org

infliximab

Home/Tag:infliximab

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label

2016-10-16T12:02:14+01:00 2011-12-1|Categories: Divulgação|Tags: , , , , , , , |

Introduction: The purpose of this observational study was to analyze the rates, characteristics and associated risk factors of severe infections in patients with systemic autoimmune diseases (SAD) who were treated off-label with biological agents in daily practice. Methods: The BIOGEAS registry is an ongoing Spanish prospective cohort study investigating the long-term safety and efficacy of the off-label use of [...]